Glyphosate, a Polar Pest Put to Test

Jun 20, 2016 | Blogs, Environmental / Industrial, Food / Beverage | 0 comments

No other pesticide has courted more media attention and controversy in recent months than glyphosate, with governments and national agencies debating its use and health effects. The following links just show some of the media attention this organophosphorus compound has received:

Download Presentation >

However irrespective of whether it poses a risk or not the analysis of glyphosate and other polar compounds in food and beverage products has been a challenge. Attaining the required sensitivity, dealing with complex matrices and sample prep can put a serious strain and demand on your laboratory. A common practice for the analysis of glyphosate and the other associated polar compounds such as AMPA, Glufosinate, and MMPA is to derivatize the samples during the preparation.

The derivatization method may be effective however there is a serious efficiency problem associated with it, the time it takes the analysts to prep and extract the sample. Derivatization can be a time-consuming procedure and can, therefore, affect a lab’s productivity, turnaround, and margins.

In a recent presentation, on the QTRAP® 6500+ System, we conducted an in-depth evaluation into the Quantitation of Underivatized Glyphosate and Other Polar Pesticides. This comprehensive study details the various techniques and LC conditions that we tested on a variety of matrices.  In this study, we show how the SelexION® reduces interferences and can meet your required levels of sensitivity.

 

How SCIEX Now empowers mass spec users to work with more control, clarity and confidence

In this interview, Andy Wilcox, Senior Market Development Manager, Aftermarket and Software, speaks with Susanna Baqué, Senior Director of Global Customer Experience, about how SCIEX Now gives customers one connected digital workspace to manage instruments, reduce time spent searching for information, resolve issues faster and keep their laboratory running more efficiently and with greater confidence.

Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies

As therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.

The rules have changed

Regulated laboratories are evolving faster than ever. New analytical modalities, higher sample throughput, increasing regulatory scrutiny, and leaner teams are reshaping how work gets done. At the same time, expectations for data integrity, standardization, and operational efficiency continue to increase complexity and/or scope. In this environment, LC-MS software is no longer simply an instrument control platform—it has become a critical part of a laboratory’s quality management system. The question is no longer whether your lab has changed, but whether your software has evolved to support the way regulated labs operate today, and if they are ready and able to meet the demands, they will face tomorrow.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network